136434-34-9 | Duloxetine, HCl

Packsize	Purity	Availability	Price	Discounted Price
1g	97%	in stock	$25.00	$17.00
5g	97%	in stock	$63.00	$44.00
25g	97%	in stock	$201.00	$141.00
100g	97%	in stock	$572.00	$400.00

Description

• Catalog Number: AD27641
• Chemical Name: Duloxetine, HCl
• CAS Number: 136434-34-9
• Molecular Formula: C18H19ClNOS
• Molecular Weight: 333.8755
• MDL Number: MFCD06407958
• SMILES: CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2.[H+].[Cl-]

Computed Properties

• Complexity: 312
• Covalently-Bonded Unit Count: 2
• Defined Atom Stereocenter Count: 1
• Heavy Atom Count: 22
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 6

Literature

• Steroidogenic disruptive effects of the serotonin-noradrenaline reuptake inhibitors duloxetine, venlafaxine and tramadol in the H295R cell assay and in a recombinant CYP17 assay.

  Toxicology in vitro : an international journal published in association with BIBRA 20180301

• Dosing pattern comparison between duloxetine and pregabalin among patients with diabetic peripheral neuropathic pain.

  Pain practice : the official journal of World Institute of Pain 20121101

• Hippocampal N-acetylaspartate and morning cortisol levels in drug-naive, first-episode patients with major depressive disorder: effects of treatment.

  Journal of psychopharmacology (Oxford, England) 20121101

• Evaluation of the effect of duloxetine treatment on functioning as measured by the Sheehan disability scale: pooled analysis of data from six randomized, double-blind, placebo-controlled clinical studies.

  International clinical psychopharmacology 20121101

• A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease.

  Expert opinion on pharmacotherapy 20121101

• Duloxetine-associated tardive dyskinesia resolved with fluvoxamine: a case report.

  Journal of clinical psychopharmacology 20121001

• A case of severe hyponatremia induced by duloxetine and ziprasidone.

  Chinese medical journal 20121001

• Evaluation of the anti-ulcerogenic activity of the antidepressants duloxetine, amitriptyline, fluoxetine and mirtazapine in different models of experimental gastric ulcer in rats.

  European journal of pharmacology 20120915

• Acute massive pulmonary thromboembolism due to acute intoxication by duloxetine: a case report.

  Cardiovascular toxicology 20120901

• Differential BDNF responses of triple versus dual reuptake inhibition in neuronal and astrocytoma cells as well as in rat hippocampus and prefrontal cortex.

  Journal of molecular neuroscience : MN 20120901

• Tolerability aspects in duloxetine-treated patients with depression: Should one use a lower starting dose in clinical practice?

  Expert opinion on drug safety 20120901

• Duloxetine for the management of pain in older adults with knee osteoarthritis: randomised placebo-controlled trial.

  Age and ageing 20120901

• Intranasal administration of nanostructured lipid carriers containing CNS acting drug: pharmacodynamic studies and estimation in blood and brain.

  Journal of psychiatric research 20120901

• A 9-week randomized trial comparing a chronotherapeutic intervention (wake and light therapy) to exercise in major depressive disorder patients treated with duloxetine.

  The Journal of clinical psychiatry 20120901

• Study of emotional and cognitive impairments in mononeuropathic rats: effect of duloxetine and gabapentin.

  Pain 20120801

• Preclinical discovery of duloxetine for the treatment of depression.

  Expert opinion on drug discovery 20120801

• Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions.

  PLoS computational biology 20120801

• Duloxetine blocks cloned Kv4.3 potassium channels.

  Brain research 20120723

• Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120701

• A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD).

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120701

• Assessing carrageenan-induced locomotor activity impairment in rats: comparison with evoked endpoint of acute inflammatory pain.

  European journal of pain (London, England) 20120701

• The efficacy of morphine, pregabalin, gabapentin, and duloxetine on mechanical allodynia is different from that on neuroma pain in the rat neuropathic pain model.

  Anesthesia and analgesia 20120701

• Etodolac, a cyclooxygenase-2 inhibitor, attenuates paclitaxel-induced peripheral neuropathy in a mouse model of mechanical allodynia.

  The Journal of pharmacology and experimental therapeutics 20120701

• Determination and validation of duloxetine hydrochloride in capsules by HPLC with pre-column derivatization and fluorescence detection.

  Journal of chromatographic science 20120701

• A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder.

  International clinical psychopharmacology 20120701

• Duloxetine use in chronic low back pain: treatment patterns and costs.

  PharmacoEconomics 20120701

• A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.

  The Journal of clinical psychiatry 20120701

• Predictors of duloxetine versus other treatments among veterans with diabetic peripheral neuropathic pain: a retrospective study.

  Pain practice : the official journal of World Institute of Pain 20120601

• Comparative effectiveness in pain-related outcomes and health care utilizations between veterans with major depressive disorder treated with duloxetine and other antidepressants: a retrospective propensity score-matched comparison.

  Pain practice : the official journal of World Institute of Pain 20120601

• Agomelatine-induced akathisia with concomitant duloxetine medication: a case report.

  Pharmacopsychiatry 20120601

• Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy.

  Pain 20120601

• A cost-utility analysis of pregabalin versus duloxetine for the treatment of painful diabetic neuropathy.

  Journal of pain & palliative care pharmacotherapy 20120601

• Early non-response in patients with severe depression: escitalopram up-titration versus switch to duloxetine.

  Clinical drug investigation 20120601

• [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline].

  Schmerz (Berlin, Germany) 20120601

• Concise enantioselective synthesis of duloxetine via direct catalytic asymmetric aldol reaction of thioamide.

  The Journal of organic chemistry 20120504

• Does pain improve earlier than mood in depressed patients with painful physical symptoms treated with duloxetine?

  Pharmacopsychiatry 20120501

• Exploratory translational modeling approach in drug development to predict human brain pharmacokinetics and pharmacologically relevant clinical doses.

  Drug metabolism and disposition: the biological fate of chemicals 20120501

• The combined predictive capacity of rat models of algogen-induced and neuropathic hypersensitivity to clinically used analgesics varies with nociceptive endpoint and consideration of locomotor function.

  Pharmacology, biochemistry, and behavior 20120501

• Apathy in currently nondepressed patients treated with a SSRI for a major depressive episode: outcomes following randomized switch to either duloxetine or escitalopram.

  Journal of psychiatric research 20120501

• Antidepressants and the relief of osteoarthritic pain - findings from a study examining adjunctive duloxetine.

  International journal of clinical practice 20120501

• A case of serotonin syndrome precipitated by fentanyl and ondansetron in a patient receiving paroxetine, duloxetine, and bupropion.

  Journal of clinical anesthesia 20120501

• Pilot study of duloxetine for cancer patients with neuropathic pain non-responsive to pregabalin.

  Anticancer research 20120501

• Predictors of pain medication selection among patients diagnosed with fibromyalgia.

  Pain practice : the official journal of World Institute of Pain 20120401

• Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120401

• Prediction of human serotonin and norepinephrine transporter occupancy of duloxetine by pharmacokinetic/pharmacodynamic modeling in the rat.

  The Journal of pharmacology and experimental therapeutics 20120401

• Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery.

  Heart, lung & circulation 20120401

• Efficacy and safety of the α4β2 neuronal nicotinic receptor agonist ABT-894 in patients with diabetic peripheral neuropathic pain.

  Pain 20120401

• Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.

  Clinical therapeutics 20120401

• A simple HPLC method for the simultaneous determination of two selective serotonin reuptake inhibitors and two serotonin-norepinephrine reuptake inhibitors in hair, nail clippings, and cerebrospinal fluid.

  Journal of separation science 20120401

• Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine.

  Pain practice : the official journal of World Institute of Pain 20120301

• Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial.

  The International journal of eating disorders 20120301

• Duloxetine HCl lipid nanoparticles: preparation, characterization, and dosage form design.

  AAPS PharmSciTech 20120301

• Predictors of remission with placebo using an integrated study database from patients with major depressive disorder.

  Current medical research and opinion 20120301

• Generalized tonic-clonic seizure secondary to duloxetine poisoning: a short report with favorable out come.

  Neurotoxicology 20120301

• Delirium associated with duloxetine in a depressed patient with Alzheimer's dementia.

  Psychiatry and clinical neurosciences 20120301

• Clinically relevant outcomes based on analysis of pooled data from 2 trials of duloxetine in patients with knee osteoarthritis.

  The Journal of rheumatology 20120201

• Frontal regional homogeneity increased and temporal regional homogeneity decreased after remission of first-episode drug-naïve major depressive disorder with panic disorder patients under duloxetine therapy for 6 weeks.

  Journal of affective disorders 20120201

• Treatment with duloxetine in adults and the incidence of cardiovascular events.

  Journal of clinical psychopharmacology 20120201

• An open-label safety and pharmacokinetics study of duloxetine in pediatric patients with major depression.

  Journal of child and adolescent psychopharmacology 20120201

• Peripheral nerve toxic effects of nitrofurantoin.

  Archives of neurology 20120201

• Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine.

  Pain practice : the official journal of World Institute of Pain 20120101

• A randomized, single-blind, comparison of duloxetine with bupropion in the treatment of SSRI-resistant major depression.

  Journal of affective disorders 20120101

• Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care.

  Journal of medical economics 20120101

• Early discontinuation and suboptimal dosing of duloxetine treatment in patients with major depressive disorder: analysis from a US third-party payer perspective.

  Journal of medical economics 20120101

• Persistent genital arousal disorder: successful treatment with duloxetine and pregabalin in two cases.

  The journal of sexual medicine 20120101

• A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode.

  International clinical psychopharmacology 20120101

• Economic evaluation of duloxetine as a first-line treatment for painful diabetic peripheral neuropathy in Mexico.

  Journal of medical economics 20120101

• Time course of improvement of different symptom clusters in patients with major depression and pain treated with duloxetine or placebo.

  Current medical research and opinion 20120101

• Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol.

  Human psychopharmacology 20120101

• Reversible ptosis probably related to duloxetine use.

  General hospital psychiatry 20120101

• A systematic review of duloxetine for osteoarthritic pain: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?

  Postgraduate medicine 20120101

• Cost-effectiveness analysis of pharmacologic treatment of fibromyalgia in Mexico.

  Reumatologia clinica 20120101

• Healthcare utilization among patients with depression before and after initiating duloxetine in the United Kingdom.

  Journal of medical economics 20120101

• Duloxetine inhibits effects of MDMA ('ecstasy') in vitro and in humans in a randomized placebo-controlled laboratory study.

  PloS one 20120101

• Stress-induced changes of hippocampal NMDA receptors: modulation by duloxetine treatment.

  PloS one 20120101

• Duloxetine in the treatment of adolescents with somatoform disorders: a report of two cases.

  Actas espanolas de psiquiatria 20120101

• Duloxetine for the treatment of overactive bladder syndrome in multiple sclerosis: a pilot study.

  Clinical neuropharmacology 20120101

• The effect of duloxetine treatment on cognition in patients with fibromyalgia.

  Psychosomatic medicine 20120101

• Acute hepatic failure involving duloxetine hydrochloride.

  The Journal of neuropsychiatry and clinical neurosciences 20120101

• Heart failure assocated with pregabalin.

  Pain physician 20120101

• Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.

  The Clinical journal of pain 20120101

• Warfarin: pharmacological profile and drug interactions with antidepressants.

  Einstein (Sao Paulo, Brazil) 20120101

• Duloxetine versus other anti-depressive agents for depression.

  The Cochrane database of systematic reviews 20120101

• Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms.

  Cancer 20111215

• Second-generation antidepressants for seasonal affective disorder.

  The Cochrane database of systematic reviews 20111207

• Polymorphism and a metastable solvate of duloxetine hydrochloride.

  Molecular pharmaceutics 20111205

• Electroretinographic assessment in major depressed patients receiving duloxetine: might differences between responders and non-responders indicate a differential biological background?

  Journal of affective disorders 20111201

• Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial.

  Current medical research and opinion 20111201

• Case scenario: opioid association with serotonin syndrome: implications to the practitioners.

  Anesthesiology 20111201

• Trajectories of depression severity in clinical trials of duloxetine: insights into antidepressant and placebo responses.

  Archives of general psychiatry 20111201

• Duloxetine's modest short-term influences in subcortical structures of first episode drug-naïve patients with major depressive disorder and panic disorder.

  Psychiatry research 20111130

• Applying medicinal chemistry transformations and multiparameter optimization to guide the search for high-quality leads and candidates.

  Journal of chemical information and modeling 20111128

• Adverse reactions to duloxetine in depression.

  Expert opinion on drug safety 20111101

• Neoteric pharmacotherapeutic targets in fibromyalgia.

  Expert opinion on therapeutic targets 20111101

• Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial.

  International clinical psychopharmacology 20111101

• Augmentative effects of fluvoxamine on duloxetine plasma levels in depressed patients.

  Pharmacopsychiatry 20111101

• Partial status epilepticus after electroconvulsive therapy and medical treatment with bupropion.

  Pharmacopsychiatry 20111101

• Duloxetine in the acute and continuation treatment of major depressive disorder.

  Expert review of neurotherapeutics 20111101

• Dosing patterns for duloxetine and predictors of high-dose prescriptions in patients with major depressive disorder: analysis from a United States third-party payer perspective.

  Clinical therapeutics 20111101

• Treatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational period.

  International journal of psychiatry in clinical practice 20111101

• Association of catechol-O-methyltransferase variants with duloxetine response in major depressive disorder.

  Psychiatry research 20111030

• Reversible time-dependent inhibition of cytochrome P450 enzymes by duloxetine and inertness of its thiophene ring towards bioactivation.

  Toxicology letters 20111030

• Early improvement in pain predicts pain response at endpoint in patients with fibromyalgia.

  The journal of pain : official journal of the American Pain Society 20111001

• Short-term duloxetine administration affects neural correlates of mood-congruent memory.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20111001

• Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study.

  Current medical research and opinion 20111001

• A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.

  Current medical research and opinion 20111001

• Effects of baseline depression severity on remission rates with duloxetine and placebo in anxious and nonanxious patients with major depression.

  Journal of clinical psychopharmacology 20111001

• Colleague interactions and new drug prescribing behavior: the case of the initial prescription of antidepressants in Taiwanese medical centers.

  Social science & medicine (1982) 20111001

• Duloxetine versus placebo in the treatment of patients with generalized anxiety disorder in China.

  Chinese medical journal 20111001

• Two-week administration of the combined serotonin-noradrenaline reuptake inhibitor duloxetine augments functioning of mesolimbic incentive processing circuits.

  Biological psychiatry 20110915

• A spinal mechanism of action for duloxetine in a rat model of painful diabetic neuropathy.

  British journal of pharmacology 20110901

• Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy.

  The International journal of neuroscience 20110901

• Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects.

  The Journal of clinical endocrinology and metabolism 20110901

• Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia.

  Current medical research and opinion 20110901

• Effects of milnacipran, duloxetine and indomethacin, in polyarthritic rats using the Randall-Selitto model.

  Behavioural pharmacology 20110901

• Safety of electroconvulsive therapy-duloxetine combination.

  The journal of ECT 20110901

• Duloxetine in the treatment of depression: an overview.

  Central nervous system agents in medicinal chemistry 20110901

• Differential conditioned fear response predicts duloxetine treatment outcome in male veterans with PTSD: a pilot study.

  Psychiatry research 20110815

• Efficacy and safety of duloxetine 60 mg and 120 mg daily in patients hospitalized for severe depression: a double-blind randomized trial.

  The Journal of clinical psychiatry 20110801

• Measurement-based care in psychiatric practice: a policy framework for implementation.

  The Journal of clinical psychiatry 20110801

• Postprostatectomy established stress urinary incontinence treated with duloxetine.

  Urology 20110801

• Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder.

  Brain, behavior, and immunity 20110801

• Duloxetine for depression and the incidence of hepatic events in adults.

  Journal of clinical psychopharmacology 20110801

• Erythema multiforme photoinduced by paroxetine and herpes simplex virus.

  Photodermatology, photoimmunology & photomedicine 20110801

• Pharmacotherapy of fibromyalgia.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110715

• Highly enantioselective bioreduction of N-methyl-3-oxo-3-(thiophen-2-yl) propanamide for the production of (S)-duloxetine.

  Biotechnology letters 20110701

• Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases.

  Current medical research and opinion 20110701

• Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.

  Mayo Clinic proceedings 20110701

• Estimation of minimum clinically important difference for pain in fibromyalgia.

  Arthritis care & research 20110601

• Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain?

  British journal of pharmacology 20110601

• Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors.

  Current medical research and opinion 20110601

• Average daily dose, medication adherence, and healthcare costs among commercially-insured patients with fibromyalgia treated with duloxetine.

  Current medical research and opinion 20110601

• Duloxetine use in painful conditions.

  Expert opinion on pharmacotherapy 20110601

• Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study.

  International journal of psychiatry in clinical practice 20110601

• A chemoenzymatic dynamic kinetic resolution approach to enantiomerically pure (R)- and (S)-duloxetine.

  The Journal of organic chemistry 20110520

• [Non-surgical treatment of female incontinence].

  MMW Fortschritte der Medizin 20110519

• Adherence and persistence with duloxetine and hospital utilization in patients with major depressive disorder.

  International clinical psychopharmacology 20110501

• Duloxetine: clinical pharmacokinetics and drug interactions.

  Clinical pharmacokinetics 20110501

• Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia.

  Current medical research and opinion 20110501

• Duloxetine-induced tako-tsubo cardiomyopathy: implications for preventing a broken heart.

  Southern medical journal 20110501

• 'Tako-tsubo' cardiomyopathy and duloxetine use.

  Southern medical journal 20110501

• Interaction between adalimumab with concurrent pregabalin and duloxetine administration in a psoriasis patient with diabetic peripheral neuropathy.

  Cutis 20110501

• [Because depression also hurts: duloxetine can help patients return to vitality].

  MMW Fortschritte der Medizin 20110407

• [Interview with Dr. Heike-Ariane Washeim, Zirndorf, and Dr. Heiner Buschmann, Übach-Palenberg (interview by Abdol A. Ameri)].

  MMW Fortschritte der Medizin 20110407

• A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.

  Journal of affective disorders 20110401

• A systematic review of duloxetine and venlafaxine in major depression, including unpublished data.

  Acta psychiatrica Scandinavica 20110401

• Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.

  Current medical research and opinion 20110401

• A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy: a randomized, double-blind, cross-over clinical trial.

  Diabetes care 20110401

• Duloxetine transfer across the placenta during pregnancy and into milk during lactation.

  Archives of women's mental health 20110401

• Predictors of relapse in a study of duloxetine treatment for patients with generalized anxiety disorder.

  Human psychopharmacology 20110401

• Clinical and functional outcomes in patients with major depressive disorder and painful physical symptoms switched to treatment with duloxetine.

  Human psychopharmacology 20110401

• Fibromyalgia and sleep.

  Best practice & research. Clinical rheumatology 20110401

• Pharmacotherapy of fibromyalgia.

  Best practice & research. Clinical rheumatology 20110401

• Efficacy, safety and tolerability of duloxetine in idiopathic trigeminal neuralgia.

  Journal of the Indian Medical Association 20110401

• Subchronic duloxetine administration alters the extended amygdala circuitry in healthy individuals.

  NeuroImage 20110315

• A subtle grey-matter increase in first-episode, drug-naive major depressive disorder with panic disorder after 6 weeks' duloxetine therapy.

  The international journal of neuropsychopharmacology 20110301

• Prediction of repeat-dose occupancy from single-dose data: characterisation of the relationship between plasma pharmacokinetics and brain target occupancy.

  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20110301

• Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis.

  Rheumatology (Oxford, England) 20110301

• Sexual function during long-term duloxetine treatment in patients with recurrent major depressive disorder.

  The journal of sexual medicine 20110301

• Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.

  International clinical psychopharmacology 20110301

• Combination of lithium and duloxetine in 2 depressed patients refractory to duloxetine monotherapy.

  Pharmacopsychiatry 20110301

• Serotonin syndrome after discontinuation of olanzapine in a combined treatment with duloxetine -- case report.

  Pharmacopsychiatry 20110301

• Burning mouth syndrome responsive to duloxetine: a case report.

  Pain medicine (Malden, Mass.) 20110301

• Hypogonadism and gynecomastia with duloxetine.

  Pharmacopsychiatry 20110301

• Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies.

  International journal of clinical practice 20110301

• Duloxetine-related panic attacks.

  Psychiatria Danubina 20110301

• Reinforcement of irritability during therapy with benzodiazepines.

  Psychiatria Danubina 20110301

• Duloxetine in the treatment of adolescents with attention deficit/hyperactivity disorder: an open-label study.

  Human psychopharmacology 20110301

• On the three-arm non-inferiority trial including a placebo with a prespecified margin.

  Statistics in medicine 20110210

• Is duloxetine useful for central neuropathic pain?

  Pain 20110201

• Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke: a randomized, double-blind, placebo-controlled trial.

  Pain 20110201

• Pseudohypoalgesia on the skin: a novel view on the paradox of pain perception in depression.

  Journal of clinical psychopharmacology 20110201

• Urinary incontinence in 2010: the evolution of SUI management.

  Nature reviews. Urology 20110201

• Atypical Stevens-Johnson syndrome in an adolescent treated with duloxetine.

  Journal of child and adolescent psychopharmacology 20110201

• A case of venlafaxine-induced bruxism alleviated by duloxetine substitution.

  Progress in neuro-psychopharmacology & biological psychiatry 20110115

• Aripiprazole augmentation induced hypertension in major depressive disorder: a case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20110115

• Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine.

  Pain 20110101

• A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee.

  Pain practice : the official journal of World Institute of Pain 20110101

• Opioid utilization and health-care costs among patients with diabetic peripheral neuropathic pain treated with duloxetine vs. other therapies.

  Pain practice : the official journal of World Institute of Pain 20110101

• Retrospective evaluation of clinical characteristics, pharmacotherapy and healthcare resource use among patients prescribed pregabalin or duloxetine for diabetic peripheral neuropathy in usual care.

  Pain practice : the official journal of World Institute of Pain 20110101

• Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia.

  Pain practice : the official journal of World Institute of Pain 20110101

• Novel antidepressants and panic disorder: evidence beyond current guidelines.

  Neuropsychobiology 20110101

• Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial.

  European urology 20110101

• Halothane-anesthetized rabbit: a new experimental model to test the effects of besipirdine and duloxetine on lower urinary tract function.

  Urologia internationalis 20110101

• Attributes of response in depressed patients switched to treatment with duloxetine.

  International journal of clinical practice 20110101

• Coma after overdose with duloxetine.

  The Annals of pharmacotherapy 20110101

• Medication adherence and healthcare costs among fibromyalgia patients treated with duloxetine.

  Pain practice : the official journal of World Institute of Pain 20110101

• Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine.

  Pain practice : the official journal of World Institute of Pain 20110101

• Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder.

  BMC psychiatry 20110101

• Pathologic grooming behavior: facial dermatillomania.

  Cutis 20110101

• Clinical and demographic predictors of improvement during duloxetine treatment in patients with major depression: an open-label study.

  Clinical drug investigation 20110101

• Retrospective audit on tolerability and efficacy of duloxetine for stress urinary incontinence.

  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20110101

• Serotonin syndrome due to duloxetine.

  Clinical neuropharmacology 20110101

• Factors associated with pain medication selection among patients diagnosed with diabetic peripheral neuropathic pain: a retrospective study.

  Journal of medical economics 20110101

• Urinary incontinence: pharmacotherapy options.

  Annals of medicine 20110101

• Cost effectiveness of duloxetine in the treatment of fibromyalgia in the United States.

  Journal of medical economics 20110101

• Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial.

  Arthritis research & therapy 20110101

• Duloxetine-related growth of putamen and brainstem in first-onset drug-naive major depressive disorder with panic disorder: a case series.

  The Journal of neuropsychiatry and clinical neurosciences 20110101

• Duloxetine-induced subcortical growth in a patient with major depressive disorder and panic disorder.

  The Journal of neuropsychiatry and clinical neurosciences 20110101

• Duloxetine-induced nocturnal bruxism resolved by buspirone: case report.

  Clinical neuropharmacology 20110101

• Galactorrhea during duloxetine treatment: a case report.

  Turk psikiyatri dergisi = Turkish journal of psychiatry 20110101

• Trajectory analysis of healthcare costs for patients with major depressive disorder treated with high doses of duloxetine.

  Journal of medical economics 20110101

• Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine.

  BMC psychiatry 20110101

• Duloxetine's effects in resting functional magnetic resonance imaging of first-episode, drug-naive major depressive disorder with panic disorder patients.

  The Journal of neuropsychiatry and clinical neurosciences 20110101

• [Biological age and the pain syndrome at diabetic polyneuropathy].

  Advances in gerontology = Uspekhi gerontologii 20110101

• Severe INR elevation related to duloxetine use: a case report.

  Psychosomatics 20110101

• Takotsubo cardiomyopathy associated with titration of duloxetine.

  Texas Heart Institute journal 20110101

• Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants.

  PloS one 20110101

• Duloxetine contributing to a successful multimodal treatment program for peripheral femoral neuropathy and comorbid 'reactive depression' in an adolescent.

  Pain research & management 20110101

• Improvement with duloxetine in primary progressive freezing gait.

  Neurology 20101207

• Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial.

  The journal of pain : official journal of the American Pain Society 20101201

• Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial.

  The Journal of rheumatology 20101201

• Factors associated with duloxetine treatment among patients with major depressive disorder in Veterans Health Administration: a retrospective study.

  Current medical research and opinion 20101201

• The effect of coadministration of duloxetine on steady-state serum concentration of risperidone and aripiprazole: a study based on therapeutic drug monitoring data.

  Therapeutic drug monitoring 20101201

• False conclusions regarding duloxetine's purported efficacy in pain among depressed patients.

  Psychiatria Danubina 20101201

• Duloxetine. Also avoid its use in recurrent depression.

  Prescrire international 20101201

• [Mirtazapine-associated hepatotoxicity].

  Medicina clinica 20101106

• [Effective treatment of depression. Early reduction of painful concomitant symptoms increases the probability of remission].

  MMW Fortschritte der Medizin 20101104

• [Interview with Dr. Armin Spingler. Management of depression in family practice].

  MMW Fortschritte der Medizin 20101104

• Artifactual formylation of the secondary amine of duloxetine hydrochloride by acetonitrile in the presence of titanium dioxide: implications for HPLC method development.

  Journal of pharmaceutical and biomedical analysis 20101102

• Initial duloxetine prescription dose and treatment adherence and persistence in patients with major depressive disorder.

  International clinical psychopharmacology 20101101

• Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network.

  Alimentary pharmacology & therapeutics 20101101

• Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis.

  Current medical research and opinion 20101101

• Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials.

  Current medical research and opinion 20101101

• Increased aripiprazole concentrations in an HIV-positive male concurrently taking duloxetine, darunavir, and ritonavir.

  The Annals of pharmacotherapy 20101101

• Analysis of duloxetine hydrochloride and its related compounds in pharmaceutical dosage forms and in vitro dissolution studies by stability indicating UPLC.

  Journal of chromatographic science 20101101

• Duloxetine in major depressed patients resistant to SSRIs and/or venlafaxine.

  Psychiatria Danubina 20101101

• Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China.

  Chinese medical journal 20101101

• In vitro and in vivo evaluation of the effects of duloxetine on P-gp function.

  Human psychopharmacology 20101101

• Effects of duloxetine treatment on brain response to painful stimulation in major depressive disorder.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20101001

• Opioid use and healthcare costs among patients with DPNP initiating duloxetine versus other treatments.

  Current medical research and opinion 20101001

• Effect of adjunctive duloxetine on the plasma concentrations of clozapine, olanzapine, and risperidone in patients with psychotic disorders.

  Journal of clinical psychopharmacology 20101001

• A case of milnacipran-related sweating alleviated by duloxetine substitution.

  Journal of clinical psychopharmacology 20101001

• [The weeping patient].

  MMW Fortschritte der Medizin 20100923

• Selective potentiation of gabapentin-mediated antinociception in the rat formalin test by the nicotinic acetylcholine receptor agonist ABT-594.

  Neuropharmacology 20100901

• Duloxetine reduces morphine requirements after knee replacement surgery.

  British journal of anaesthesia 20100901

• Study on the binding of chiral drug duloxetine hydrochloride to human serum albumin.

  European journal of medicinal chemistry 20100901

• Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies.

  Current medical research and opinion 20100901

• Block of neuronal Na+ channels by antidepressant duloxetine in a state-dependent manner.

  Anesthesiology 20100901

• Duloxetine for the treatment of fibromyalgia.

  Expert review of clinical immunology 20100901

• Treatment of neuropathic pain.

  Seminars in neurology 20100901

• Characterization of glutathione conjugates of duloxetine by mass spectrometry and evaluation of in silico approaches to rationalize the site of conjugation for thiophene containing drugs.

  Chemical research in toxicology 20100816

• Successful duloxetine treatment of a binge eating disorder: a case report.

  Journal of psychopharmacology (Oxford, England) 20100801

• Effects of adjunctive reboxetine in patients with duloxetine-resistant depression: a 12-week prospective study.

  Journal of psychopharmacology (Oxford, England) 20100801

• Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels.

  Journal of psychopharmacology (Oxford, England) 20100801

• Analytic model comparing the cost utility of TVT versus duloxetine in women with urinary stress incontinence.

  International urogynecology journal 20100801

• The predictive value of pre-treatment cystometry in the outcome of women with mixed incontinence treated with duloxetine.

  European journal of obstetrics, gynecology, and reproductive biology 20100801

• Cost-effectiveness of duloxetine: the Stress Urinary Incontinence Treatment (SUIT) study.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20100801

• Alpha2-adrenoceptor blockade potentiates the effect of duloxetine on sneeze induced urethral continence reflex in rats.

  The Journal of urology 20100801

• Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients.

  Drugs & aging 20100801

• Treating diabetic peripheral neuropathic pain.

  American family physician 20100715

• [Evidence-based recommendations for the treatment of fibromyalgia syndrome].

  Zeitschrift fur Rheumatologie 20100701

• Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.

  International clinical psychopharmacology 20100701

• Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials.

  Expert opinion on drug safety 20100701

• Non-length-dependent small fibre neuropathy. Confocal microscopy study of the corneal innervation.

  Journal of neurology, neurosurgery, and psychiatry 20100701

• Duloxetine for the treatment of generalized social anxiety disorder: a preliminary randomized trial of increased dose to optimize response.

  CNS spectrums 20100701

• The treatment of stress incontinence in men: part 2 of a series of articles on incontinence.

  Deutsches Arzteblatt international 20100701

• Urinary incontinence in the elderly: part 3 of a series of articles on incontinence.

  Deutsches Arzteblatt international 20100701

• [Design, synthesis and antidepressive activity of duloxetine derivatives].

  Yao xue xue bao = Acta pharmaceutica Sinica 20100701

• Comparison of neurogenic effects of fluoxetine, duloxetine and running in mice.

  Brain research 20100623

• Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.

  Seminars in arthritis and rheumatism 20100601

• Duloxetine and care management treatment of older adults with comorbid major depressive disorder and chronic low back pain: results of an open-label pilot study.

  International journal of geriatric psychiatry 20100601

• Relationship between TSH levels in the normal range and short-term duloxetine efficacy.

  Journal of affective disorders 20100601

• Major Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery.

  Journal of affective disorders 20100601

• Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients.

  Biological psychiatry 20100601

• Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome.

  The journal of pain : official journal of the American Pain Society 20100601

• Efficacy and safety of duloxetine in patients with chronic low back pain.

  Spine 20100601

• Lymphocytic colitis under treatment with duloxetine.

  Zeitschrift fur Gastroenterologie 20100601

• Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder.

  Psychiatry research 20100530

• First preliminary results of a single case report: duloxetine might improve some symptoms of attention-deficit hyperactivity disorder.

  European psychiatry : the journal of the Association of European Psychiatrists 20100501

• Long-Term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms.

  Molecular pharmacology 20100501

• Urinary flow and urinary symptoms in elderly males exposed to either escitalopram or duloxetine.

  Current medical research and opinion 20100501

• Duloxetine 60 mg/day for the prevention of depressive recurrences: post hoc analyses from a recurrence prevention study.

  International journal of clinical practice 20100501

• Adverse events, toxicity and post-mortem data on duloxetine: case reports and literature survey.

  Journal of forensic and legal medicine 20100501

• Effects of varying degrees of renal impairment on the pharmacokinetics of duloxetine: analysis of a single-dose phase I study and pooled steady-state data from phase II/III trials.

  Clinical pharmacokinetics 20100501

• Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies.

  Drug safety 20100501

• Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain.

  Expert opinion on pharmacotherapy 20100501

• Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature.

  Expert opinion on pharmacotherapy 20100501

• Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study.

  Pain medicine (Malden, Mass.) 20100501

• New drug treatments for urinary incontinence.

  Maturitas 20100401

• Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.

  Current medical research and opinion 20100401

• [Conservative management of postoperative urinary incontinence in men].

  Der Urologe. Ausg. A 20100401

• Mixed incontinence: current evidence and future perspectives.

  Neurourology and urodynamics 20100401

• Duloxetine related hypersexuality: a case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20100317

• Determination of duloxetine hydrochloride in the presence of process and degradation impurities by a validated stability-indicating RP-LC method.

  Journal of pharmaceutical and biomedical analysis 20100311

• [Focus on treatment success of depressed patients. Early and significant pain reduction improves chances for remission].

  MMW Fortschritte der Medizin 20100304

• Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot study.

  Journal of psychopharmacology (Oxford, England) 20100301

• Reductions in stress urinary incontinence episodes: what is clinically important for women?

  Neurourology and urodynamics 20100301

• Effects of duloxetine in treatment-refractory men with posttraumatic stress disorder.

  Pharmacopsychiatry 20100301

• [The effects of duloxetine on beta-actin stress response in rat brain].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20100301

• Management of depression in the presence of pain symptoms.

  Psychiatria Danubina 20100301

• The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders.

  The journal of pain : official journal of the American Pain Society 20100201

• Comparison of mechanical allodynia and the affective component of inflammatory pain in rats.

  Neuropharmacology 20100201

• Duloxetine related effects of brain structure on a patient of major depressive disorder with panic disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20100201

• Tinnitus in postherpetic neuralgia.

  The journal of headache and pain 20100201

• Comparison of milnacipran, duloxetine and pregabalin in the formalin pain test and in a model of stress-induced ultrasonic vocalizations in rats.

  Neuroscience research 20100201

• Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence.

  Current medical research and opinion 20100201

• Duloxetine-modulating effects of brain structure in major depressive disorder with panic disorder.

  Journal of clinical psychopharmacology 20100201

• [Treatment of neuropathies].

  Orvosi hetilap 20100110

• Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland.

  Journal of affective disorders 20100101

• Patient characteristics impacting health state index scores, measured by the EQ-5D of females with stress urinary incontinence symptoms.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20100101

• Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.

  Depression and anxiety 20100101

• Pharmacological treatment of fibromyalgia syndrome: new developments.

  Drugs 20100101

• Drugs to treat fibromyalgia - the transatlantic difference.

  Current opinion in investigational drugs (London, England : 2000) 20100101

• A case study of salami slicing: pooled analyses of duloxetine for depression.

  Psychotherapy and psychosomatics 20100101

• The market lifecycle of duloxetine for urinary incontinence in Norway.

  Acta obstetricia et gynecologica Scandinavica 20100101

• A presumed case of phantom limb pain treated successfully with duloxetine and pregabalin.

  General hospital psychiatry 20100101

• Stability-indicating RP-HPLC method development and validation for duloxetine hydrochloride in tablets.

  Journal of AOAC International 20100101

• Continuation treatment of major depressive disorder: is there a case for duloxetine?

  Drug design, development and therapy 20100101

• Correction of venlafaxine- and duloxetine-induced transaminase elevations with desvenlafaxine in a patient with Gilbert's syndrome.

  CNS spectrums 20100101

• The relationship between average daily dose, medication adherence, and health-care costs among diabetic peripheral neuropathic pain patients initiated on duloxetine therapy.

  Pain practice : the official journal of World Institute of Pain 20100101

• [Duloxetine in the treatment of chronic migraine].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101

• Pain response profile of patients with fibromyalgia treated with duloxetine.

  The Clinical journal of pain 20100101

• Effect of duloxetine in patients with fibromyalgia: tiredness subgroups.

  Arthritis research & therapy 20100101

• Long lasting pain hypersensitivity following ligation of the tendon of the masseter muscle in rats: a model of myogenic orofacial pain.

  Molecular pain 20100101

• The effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literature.

  International journal of immunopathology and pharmacology 20100101

• Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden.

  Journal of medical economics 20100101

• [Duloxetine].

  Revue de l'infirmiere 20100101

• A case report of transient but clinically relevant interaction between methadone and duloxetine: a reply to McCance-Katz et al.

  The American journal on addictions 20100101

• Duloxetine: a review of its pharmacology and use in chronic pain management.

  Regional anesthesia and pain medicine 20100101

• Duloxetine versus venlafaxine in the treatment of unipolar and bipolar depression.

  La Clinica terapeutica 20100101

• Efficacy and safety of duloxetine in fibromyalgia.

  La Clinica terapeutica 20100101

• Evaluation of healthcare resource utilization and costs in employees with pain associated with diabetic peripheral neuropathy treated with pregabalin or duloxetine.

  Journal of medical economics 20100101

• Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review.

  BMC neurology 20100101

• Duloxetine-related tardive dystonia and tardive dyskinesia: a case report.

  General hospital psychiatry 20100101

• Duloxetine treatment of long-term ketamine abuse-related lower urinary tract symptoms: a case report.

  General hospital psychiatry 20100101

• Duloxetine in military posttraumatic stress disorder.

  Psychopharmacology bulletin 20100101

• Stress degradation studies and kinetic determinations of duloxetine enteric-coated pellets by HPLC.

  Journal of AOAC International 20100101

• [Expel the fear of pain. Breaking of chronicity by re-learning].

  MMW Fortschritte der Medizin 20091210

• Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial.

  Pain 20091201

• The short- and long-term effect of duloxetine on painful physical symptoms in patients with generalized anxiety disorder: results from three clinical trials.

  Journal of anxiety disorders 20091201

• Effects of duloxetine on the pharmacodynamics and pharmacokinetics of warfarin at steady state in healthy subjects.

  Journal of clinical pharmacology 20091201

• How are women with SUI-symptoms treated with duloxetine in real life practice? - preliminary results from a large observational study in Germany.

  International journal of clinical practice 20091201

• [Pharmacological treatment for stress urinary incontinence in prostate cancer].

  Archivos espanoles de urologia 20091201

• Unexplained high fever in an elderly patient treated with clonidine, duloxetine, and atorvastatin.

  Clinical therapeutics 20091201

• Serotonin syndrome in an octogenarian after switch from fluoxetine to duloxetine.

  Journal of the American Geriatrics Society 20091201

• A treatment algorithm for neuropathic pain: an update.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20091201

• Duloxetine related binge eating behaviors: a case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20091113

• Duloxetine for major depressive episodes in the course of psychotic disorders: an observational clinical trial.

  Journal of psychopharmacology (Oxford, England) 20091101

• Plasma levels and cerebrospinal fluid penetration by duloxetine in a patient with a non-fatal overdose during a suicide attempt.

  The international journal of neuropsychopharmacology 20091101

• Duloxetine for pathological laughing and crying.

  The international journal of neuropsychopharmacology 20091101

• Use of duloxetine in pregnancy and lactation.

  The Annals of pharmacotherapy 20091101

• What makes patients with fibromyalgia feel better? Correlations between Patient Global Impression of Improvement and changes in clinical symptoms and function: a pooled analysis of 4 randomized placebo-controlled trials of duloxetine.

  The Journal of rheumatology 20091101

• Evaluation of anti-obesity activity of duloxetine in comparison with sibutramine along with its anti-depressant activity: an experimental study in obese rats.

  Canadian journal of physiology and pharmacology 20091101

• Abnormal gait, due to inflammation but not nerve injury, reflects enhanced nociception in preclinical pain models.

  Brain research 20091027

• Highly enantioselective Friedel-Crafts reaction of thiophenes with glyoxylates: formal synthesis of duloxetine.

  Organic letters 20091015

• Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.

  Journal of medicinal chemistry 20091008

• Duloxetine for treating painful neuropathy or chronic pain.

  The Cochrane database of systematic reviews 20091007

• Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain.

  Diabetes/metabolism research and reviews 20091001

• Current progress in the pharmacological therapy of fibromyalgia.

  Expert opinion on investigational drugs 20091001

• Recurrent episodes of serotonin-reuptake inhibitor-mediated hyponatremia in an elderly patient.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20091001

• [Combination of dialectic and behavioral therapy (DBT) and duloxetin in kleptomania].

  Psychiatrische Praxis 20090901

• Duloxetine treatment for women with premenstrual dysphoric disorder: a single-blind trial.

  The international journal of neuropsychopharmacology 20090901

• Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression.

  The international journal of neuropsychopharmacology 20090901

• A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain.

  European journal of neurology 20090901

• Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials.

  Clinical rheumatology 20090901

• Successful pain relief of cutaneous leiomyomata due to reed syndrome with the combination treatment of pregabalin and duloxetine.

  Journal of pain and symptom management 20090901

• Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain.

  Journal of medical economics 20090901

• Medical management of stress urinary incontinence: is there a future?

  Current urology reports 20090901

• Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) survey.

  Pharmacopsychiatry 20090901

• [Therapy for urinary incontinence in general practice].

  Aktuelle Urologie 20090801

• Duloxetine in obese binge eater outpatients: preliminary results from a 12-week open trial.

  Human psychopharmacology 20090801

• Stress degradation studies on duloxetine hydrochloride and development of an RP-HPLC method for its determination in capsule formulation.

  Journal of chromatographic science 20090801

• Rapid HPLC method for the simultaneous monitoring of duloxetine, venlaflaxine, fluoxetine and paroxetine in biofluids.

  Bioanalysis 20090801

• Duloxetine-induced hypomania: case report and brief review of the literature on SNRIs-induced mood switching.

  Journal of psychopharmacology (Oxford, England) 20090701

• Improvement with duloxetine in an adult ADHD patient.

  Journal of attention disorders 20090701

• Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study.

  Human psychopharmacology 20090701

• Duloxetine: in patients with fibromyalgia.

  Drugs 20090618

• Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) treatment for Isaacs syndrome with depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20090615

• Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder.

  Journal of psychiatric research 20090601

• The facilitatory effect of duloxetine combined with pelvic floor muscle training on the excitability of urethral sphincter motor neurons.

  International urogynecology journal and pelvic floor dysfunction 20090601

• Serotonin syndrome induced by duloxetine.

  The Australian and New Zealand journal of psychiatry 20090601

• A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia.

  The Clinical journal of pain 20090601

• Total residue analysis of swabs by ion mobility spectrometry.

  Analytical chemistry 20090601

• Psychogenic tremor in a patient with a major depressive episode.

  South Dakota medicine : the journal of the South Dakota State Medical Association 20090601

• [Mechanism of action of new generation antidepressants under development in Japan: focusing on dopamine neurotransmission].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20090601

• Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials.

  CNS spectrums 20090601

• [Treatment of female urinary incontinence].

  MMW Fortschritte der Medizin 20090528

• [Psycho- and pharmacotherapy of depressions. So you combine correctly].

  MMW Fortschritte der Medizin 20090507

• Severe and symptomatic hyponatremia following duloxetine treatment.

  Journal of psychopharmacology (Oxford, England) 20090501

• Effect of antidepressants on melatonin metabolite in depressed patients.

  Journal of psychopharmacology (Oxford, England) 20090501

• Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090501

• Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.

  Biological psychiatry 20090501

• Nontricyclic antidepressants for neuropathic pain #187.

  Journal of palliative medicine 20090501

• Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.

  Clinical therapeutics 20090501

• Duloxetine in the prevention of depressive recurrences: a randomized, double-blind, placebo-controlled trial.

  The Journal of clinical psychiatry 20090501

• Determination of duloxetine in human plasma by capillary electrophoresis with laser-induced fluorescence detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090415

• Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods.

  Human psychopharmacology 20090401

• Duloxetine in the management of elderly patients with major depressive disorder: an analysis of published data.

  Expert opinion on pharmacotherapy 20090401

• Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study.

  The Journal of clinical psychiatry 20090401

• [Severe forms of depression: the efficacy of escitalopram].

  L'Encephale 20090401

• Antidepressant-associated myoclonic status in a patient with symptomatic generalized epilepsy: does risk occur with therapeutic doses?

  Epilepsy & behavior : E&B 20090401

• Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder.

  Journal of affective disorders 20090301

• Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.

  Neurochemical research 20090301

• [Is medical therapy useful in the management of stress urinary incontinence?].

  Der Urologe. Ausg. A 20090301

• When worlds collide: urinary incontinence and female sexuality.

  The American journal of nursing 20090301

• Anti-nociceptive effect of duloxetine in mouse model of diabetic neuropathic pain.

  Indian journal of experimental biology 20090301

• Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.

  The Journal of clinical psychiatry 20090210

• Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial.

  Psychological medicine 20090201

• Switching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: effects on painful physical symptoms of depression.

  Journal of psychiatric research 20090201

• Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).

  Journal of psychiatric research 20090201

• A single-blind, placebo run-in study of duloxetine for activity-limiting osteoarthritis pain.

  The journal of pain : official journal of the American Pain Society 20090201

• A continuous responder analysis from a long-term trial of duloxetine treatment for generalized anxiety disorder: implications for the randomized withdrawal relapse prevention study design.

  Journal of clinical psychopharmacology 20090201

• Duloxetine in the treatment of generalized anxiety disorder.

  Expert review of neurotherapeutics 20090201

• Effective treatment of narcolepsy-cataplexy with duloxetine: a report of three cases.

  Sleep medicine 20090101

• Duloxetine: an emerging evidence for fibromyalgia.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20090101

• Non-fatal overdose of duloxetine in combination with other antidepressants and benzodiazepines.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions.

  Journal of diabetes and its complications 20090101

• Neurobehavioral and genotoxic parameters of duloxetine in mice using the inhibitory avoidance task and comet assay as experimental models.

  Pharmacological research 20090101

• Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients.

  Current drug safety 20090101

• Early symptom change prediction of remission in depression treatment.

  Psychopharmacology bulletin 20090101

• Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain.

  BMC neurology 20090101

• A validated stability indicating rapid LC method for duloxetine HCl.

  Die Pharmazie 20090101

• Open-label support for duloxetine for the treatment of panic disorder.

  CNS neuroscience & therapeutics 20090101

• Treatment of neuropsychiatric symptoms associated with euthyroid Hashimoto thyroiditis with antidepressants: a case report.

  General hospital psychiatry 20090101

• [Cymbalta (duloxetine) in the treatment of anxiety-depressive disorders in patients with discirculatory encephalopathy].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101

• [Cymbalta in the treatment of chronic pain syndromes].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101

• Population pharmacokinetics of orally administered duloxetine in patients: implications for dosing recommendation.

  Clinical pharmacokinetics 20090101

• Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial.

  Trials 20090101

• Quality of life measurement in antidepressant trials. Is there an added value?

  Psychotherapy and psychosomatics 20090101

• Stress incontinence.

  BMJ clinical evidence 20090101

• Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study.

  Pain medicine (Malden, Mass.) 20090101

• Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

  CNS drugs 20090101

• High-dose duloxetine for treatment-resistant obsessive-compulsive disorder: a case report with sustained full remission.

  Clinical neuropharmacology 20090101

• Does pain cause the perception of fatigue in patients with chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.

  Pain practice : the official journal of World Institute of Pain 20090101

• Update on duloxetine for the management of stress urinary incontinence.

  Clinical interventions in aging 20090101

• Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.

  The Clinical journal of pain 20090101

• Duloxetine for the treatment of recurrent major depressive disorder in elderly patients: treatment outcomes in patients with comorbid arthritis.

  Psychosomatics 20090101

• Switching to duloxetine remits ziprasidone - associated urinary incontinence and improves neuropsychiatric behavior in dementia: possible relationship of incontinence to 5HT2 receptor blockade.

  Psychopharmacology bulletin 20090101

• The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis.

  Drug safety 20090101

• Duloxetine in treating medically unexplained pain and Raynaud's phenomenon.

  The Journal of neuropsychiatry and clinical neurosciences 20090101

• [A naturalistic study comparing two initial duloxetine dosing strategies in a clinical 'real world' setting].

  Rivista di psichiatria 20090101

• Study on fluorescence characteristics of duloxetine hydrochloride.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20081201

• Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.

  Journal of pain and symptom management 20081201

• Basal and stress-induced modulation of activity-regulated cytoskeletal associated protein (Arc) in the rat brain following duloxetine treatment.

  Psychopharmacology 20081201

• An assessment of drug-drug interactions: the effect of desvenlafaxine and duloxetine on the pharmacokinetics of the CYP2D6 probe desipramine in healthy subjects.

  Drug metabolism and disposition: the biological fate of chemicals 20081201

• Antidepressant-induced sweating alleviated by aripiprazole.

  Journal of clinical psychopharmacology 20081201

• Fibromyalgia coverage uneven despite recent drug approvals.

  Managed care (Langhorne, Pa.) 20081201

• Central sensitisation phenomena in primary headaches: overview of a preventive therapeutic approach.

  CNS & neurological disorders drug targets 20081201

• Multiplicative interactions to enhance gabapentin to treat neuropathic pain.

  European journal of pharmacology 20081119

• The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder.

  Current medical research and opinion 20081101

• Clinical impact of duloxetine treatment on sleep in patients with major depressive disorder.

  International clinical psychopharmacology 20081101

• Is duloxetine effective treatment for depression with atypical features?

  International clinical psychopharmacology 20081101

• [Dermatological side effects during therapy with serotonin noradrenaline reuptake inhibitors].

  Der Nervenarzt 20081101

• Effect of desvenlafaxine on the cytochrome P450 2D6 enzyme system.

  Journal of psychiatric practice 20081101

• Response to: Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can affect placebo factors.

  Pain 20081015

• Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment.

  Journal of psychiatric research 20081001

• Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint.

  Journal of psychiatric research 20081001

• Duloxetine-associated tachycardia.

  The Annals of pharmacotherapy 20081001

• Duloxetine treatment of social anxiety disorder with comorbid major depression.

  Journal of clinical psychopharmacology 20081001

• Development and validation of chiral LC method for the enantiomeric separation of duloxetine on amylose based stationary phase.

  Journal of chromatographic science 20081001

• Duloxetine for the treatment of fibromyalgia.

  Drugs of today (Barcelona, Spain : 1998) 20081001

• Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20080901

• Dissociable effects of acute antidepressant drug administration on subjective and emotional processing measures in healthy volunteers.

  Psychopharmacology 20080901

• The relationship between functional outcomes and the treatment of anxious and painful somatic symptoms in patients with generalized anxiety disorder.

  Current medical research and opinion 20080901

• A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapy.

  The Journal of clinical psychiatry 20080901

• An 8-week, open-label trial of duloxetine for comorbid major depressive disorder and chronic headache.

  The Journal of clinical psychiatry 20080901

• A case of apical ballooning cardiomyopathy associated with duloxetine.

  Annals of internal medicine 20080805

• Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies.

  Human psychopharmacology 20080801

• Duloxetine (cymbalta) for fibromyalgia.

  The Medical letter on drugs and therapeutics 20080728

• Duloxetine 1 year on: the long-term outcome of a cohort of women prescribed duloxetine.

  International urogynecology journal and pelvic floor dysfunction 20080701

• Long-term efficacy of duloxetine in women with stress urinary incontinence.

  BJU international 20080701

• Effect of duloxetine, a norepinephrine and serotonin reuptake inhibitor, on sneeze-induced urethral continence reflex in rats.

  American journal of physiology. Renal physiology 20080701

• Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials.

  International clinical psychopharmacology 20080701

• The influence of smoking on the serum level of duloxetine.

  Pharmacopsychiatry 20080701

• Answers to the most common questions about the hepatic safety profile of duloxetine.

  Postgraduate medicine 20080701

• In vitro stability, potency, and dissolution of duloxetine enteric-coated pellets after exposure to applesauce, apple juice, and chocolate pudding.

  Clinical therapeutics 20080701

• Serious suicide attempt with duloxetine treatment.

  Southern medical journal 20080701

• Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence.

  Maturitas 20080620

• Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors.

  Pain 20080601

• Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.

  Pain 20080601

• Heart failure worsening and exacerbation after venlafaxine and duloxetine therapy.

  The Annals of pharmacotherapy 20080601

• Compelling or irrelevant? Using number needed to treat can help decide.

  Acta psychiatrica Scandinavica 20080601

• Wine and drug evaluations: lessons on making comparisons of noninferiority.

  Journal of psychopharmacology (Oxford, England) 20080601

• Establishing non-inferiority in treatment trials in psychiatry: guidelines from an Expert Consensus Meeting.

  Journal of psychopharmacology (Oxford, England) 20080601

• A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.

  Journal of psychopharmacology (Oxford, England) 20080601

• Measurement of pain and medication effect in a study of duloxetine.

  The Journal of clinical psychiatry 20080601

• A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression.

  Journal of affective disorders 20080501

• BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake.

  Cellular and molecular neurobiology 20080501

• Glossopharyngeal neuralgia with cardiac syncope: an idiopathic case treated with carbamazepine and duloxetine.

  European journal of neurology 20080501

• Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine.

  International clinical psychopharmacology 20080501

• Treatment of seasonal affective disorder with duloxetine: an open-label study.

  Pharmacopsychiatry 20080501

• Hepatic effects of duloxetine-I: non-clinical and clinical trial data.

  Current drug safety 20080501

• Hepatic effects of duloxetine-II: spontaneous reports and epidemiology of hepatic events.

  Current drug safety 20080501

• Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources.

  Current drug safety 20080501

• At-line quantitative ion mobility spectrometry for direct analysis of swabs for pharmaceutical manufacturing equipment cleaning verification.

  Analytical chemistry 20080415

• Time to response for duloxetine 60 mg once daily versus placebo in elderly patients with major depressive disorder.

  International psychogeriatrics 20080401

• A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder.

  Current medical research and opinion 20080401

• Human health risk assessments for three neuropharmaceutical compounds in surface waters.

  Regulatory toxicology and pharmacology : RTP 20080401

• Duloxetine in the treatment of major psychiatric and neuropathic disorders.

  Expert review of neurotherapeutics 20080401

• Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women.

  Annals of internal medicine 20080318

• Clinical practice. Urinary stress incontinence in women.

  The New England journal of medicine 20080306

• Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series.

  Journal of psychopharmacology (Oxford, England) 20080301

• Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability.

  The Journal of clinical psychiatry 20080301

• Nonsurgical treatment of stress urinary incontinence (SUI): grading of evidence in systematic reviews.

  BJOG : an international journal of obstetrics and gynaecology 20080301

• Duloxetine for premenstrual dysphoric disorder: a pilot study.

  Expert opinion on pharmacotherapy 20080301

• The hepatic safety profile of duloxetine: a review.

  Expert opinion on drug metabolism & toxicology 20080301

• Successful duloxetine use to prevent venlafaxine withdrawal symptoms.

  Progress in neuro-psychopharmacology & biological psychiatry 20080215

• Duloxetine treatment of Premenstrual Dysphoric Disorder: case reports.

  Progress in neuro-psychopharmacology & biological psychiatry 20080215

• Diabetic neuropathy: new strategies for treatment.

  Diabetes, obesity & metabolism 20080201

• Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK.

  Current medical research and opinion 20080201

• Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats.

  Behavioural pharmacology 20080201

• Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder.

  Journal of clinical psychopharmacology 20080201

• Suicidal ideation associated with duloxetine use: a case series.

  Journal of clinical psychopharmacology 20080201

• Successful treatment of nicotine withdrawal with duloxetine: a case report.

  Journal of clinical psychopharmacology 20080201

• Duloxetine-induced cutaneous adverse reaction.

  Journal of clinical psychopharmacology 20080201

• Successful treatment of chronic fatigue syndrome with duloxetine and trijodthyronine--a case study.

  Journal of clinical psychopharmacology 20080201

• Combining mirtazapine and duloxetine in treatment-resistant depression improves outcomes and sexual function.

  Journal of clinical psychopharmacology 20080201

• The effect of duloxetine on urethral sphincter morphology.

  Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 20080201

• The treatment of urinary incontinence with Duloxetine.

  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20080201

• Nonparametric empirical Bayes method for comparison of treatment effects with application to stress urinary incontinence data.

  Pharmaceutical statistics 20080101

• Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.

  Depression and anxiety 20080101

• A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.

  Journal of psychiatric research 20080101

• Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence.

  Neurourology and urodynamics 20080101

• Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.

  Depression and anxiety 20080101

• Long-term tolerability and effectiveness of duloxetine in the treatment of major depressive disorder.

  Depression and anxiety 20080101

• Duloxetine as a treatment for stress incontinence--where are we now?

  International urogynecology journal and pelvic floor dysfunction 20080101

• Duloxetine does not relieve painful physical symptoms in depression: a meta-analysis.

  Psychotherapy and psychosomatics 20080101

• Pharmacokinetics of duloxetine in breast milk and plasma of healthy postpartum women.

  Clinical pharmacokinetics 20080101

• Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial.

  BMC urology 20080101

• [Toxicity in overdoses with new antidepressive agents. A survey of records shows different severity symptoms for different agents].

  Lakartidningen 20080101

• In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine.

  Clinical pharmacokinetics 20080101

• Switching to duloxetine from selective serotonin reuptake inhibitor antidepressants: a multicenter trial comparing 2 switching techniques.

  The Journal of clinical psychiatry 20080101

• The use of Duloxetine in the treatment of male stress urinary incontinence.

  Wiener medizinische Wochenschrift (1946) 20080101

• Efficacy of duloxetine for the treatment of depression: relationship to most recent antidepressant trial.

  Psychopharmacology bulletin 20080101

• Treating the physical symptoms of depression with second-generation antidepressants: a systematic review and metaanalysis.

  Psychosomatics 20080101

• [Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].

  L'Encephale 20080101

• Shock-like sensations associated with duloxetine discontinuation.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20080101

• Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials.

  BMC neurology 20080101

• The history and treatment of a bipolar patient diagnosed with Borna disease virus infection. Case report.

  APMIS. Supplementum 20080101

• Antidepressant behavioral effects of duloxetine and amitriptyline in the rat forced swimming test.

  Acta cirurgica brasileira 20080101

• Urinary retention during combined treatment of postpsychotic depression with duloxetine and olanzapine.

  Clinical neuropharmacology 20080101

• Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.

  PharmacoEconomics 20080101

• A cost-utility comparison of four first-line medications in painful diabetic neuropathy.

  PharmacoEconomics 20080101

• The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20080101

• Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20080101

• [Chronic pain and depression].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101

• Dopamine D(1) and D(2) receptor agonism enhances antinociception mediated by the serotonin and noradrenaline reuptake inhibitor duloxetine in the rat formalin test.

  European journal of pharmacology 20071201

• Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder.

  Journal of clinical psychopharmacology 20071201

• Mixed urinary incontinence: continuing to confound?

  Current opinion in obstetrics & gynecology 20071201

• Measurement of duloxetine in blood using high-performance liquid chromatography with spectrophotometric detection and column switching.

  Therapeutic drug monitoring 20071201

• A comparison of initial duloxetine dosing strategies in patients with major depressive disorder.

  The Journal of clinical psychiatry 20071201

• Review of duloxetine in the management of diabetic peripheral neuropathic pain.

  Vascular health and risk management 20071201

• Potential drug-drug interaction between duloxetine and acenocoumarol in a patient with Alzheimer's disease.

  Clinical therapeutics 20071201

• Response to duloxetine in a depressed, treatment-resistant adolescent female.

  Journal of child and adolescent psychopharmacology 20071201

• Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20071101

• Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression.

  International clinical psychopharmacology 20071101

• Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.

  The Journal of clinical psychiatry 20071101

• Determination of duloxetine in human plasma by liquid chromatography with atmospheric pressure ionization-tandem mass spectrometry and its application to pharmacokinetic study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071015

• Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials.

  Journal of women's health (2002) 20071001

• [Conservative treatment of urinary incontinence].

  MMW Fortschritte der Medizin 20070920

• HPLC analysis of the novel antidepressant duloxetine in human plasma after an original solid-phase extraction procedure.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070901

• Involvement of reflex urethral closure mechanisms in urethral resistance under momentary stress condition induced by electrical stimulation of rat abdomen.

  American journal of physiology. Renal physiology 20070901

• Duloxetine status.

  Pain medicine (Malden, Mass.) 20070901

• Diabetic peripheral neuropathic pain: recognition and management.

  Pain medicine (Malden, Mass.) 20070901

• Assessing the impact of pharmacologic intervention on the quality of life in diabetic peripheral neuropathic pain and fibromyalgia.

  Pain medicine (Malden, Mass.) 20070901

• Safety profile of treatment in diabetic peripheral neuropathic pain.

  Pain medicine (Malden, Mass.) 20070901

• Duloxetine and other antidepressants in the treatment of patients with fibromyalgia.

  Pain medicine (Malden, Mass.) 20070901

• An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.

  Pain medicine (Malden, Mass.) 20070901

• Efficacy of duloxetine as a migraine preventive medication: possible predictors of response in a retrospective chart review.

  Headache 20070901

• Effect of dose escalation on the tolerability and efficacy of duloxetine in the treatment of women with stress urinary incontinence.

  International urogynecology journal and pelvic floor dysfunction 20070801

• Duloxetine compared with placebo for treating women with symptoms of overactive bladder.

  BJU international 20070801

• The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity.

  International journal of clinical practice 20070801

• Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine.

  International journal of clinical practice 20070801

• Duloxetine--three birds with one stone?

  International journal of clinical practice 20070801

• Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.

  International journal of clinical practice 20070801

• An overview of stress urinary incontinence treatment in women.

  Aging clinical and experimental research 20070801

• Practical management strategies for the chronic pain patient.

  The Journal of family practice 20070801

• Duloxetine treatment of stress urinary incontinence in women: effects of demographics, obesity, chronic lung disease, hypoestrogenism, diabetes mellitus, and depression on efficacy.

  European journal of obstetrics, gynecology, and reproductive biology 20070701

• The effects of duloxetine on urethral function and sphincter morphology.

  International urogynecology journal and pelvic floor dysfunction 20070701

• Duloxetine increases stage 3 sleep and suppresses rapid eye movement (REM) sleep in patients with major depression.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070701

• A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder.

  Current medical research and opinion 20070701

• Hyperprolactinemia and galactorrhea induced by serotonin and norepinephrine reuptake inhibiting antidepressants.

  The American journal of psychiatry 20070701

• Manic switching in patients receiving duloxetine.

  The American journal of psychiatry 20070701

• Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.

  The journal of sexual medicine 20070701

• Successful treatment of refractory hypochondriasis with duloxetine.

  Progress in neuro-psychopharmacology & biological psychiatry 20070630

• Pharmacological validation of a model of cystitis pain in the mouse.

  Neuroscience letters 20070629

• [Stress urinary incontinence in women--current treatment alternatives].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20070628

• Pharmacologic treatment in postprostatectomy stress urinary incontinence.

  European urology 20070601

• Development and validation of a liquid chromatography-tandem mass spectrometric method for the determination of the major metabolites of duloxetine in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070601

• Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.

  Psychiatry and clinical neurosciences 20070601

• Duloxetine in the treatment of social anxiety disorder.

  Journal of clinical psychopharmacology 20070601

• Recurrent hyponatremia after substitution of citalopram with duloxetine.

  Journal of clinical psychopharmacology 20070601

• Update on pharmacotherapy guidelines for treatment of neuropathic pain.

  Current pain and headache reports 20070601

• Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.

  The American journal of psychiatry 20070601

• Burning mouth syndrome: will better understanding yield better management?

  Pain practice : the official journal of World Institute of Pain 20070601

• Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.

  Current medical research and opinion 20070601

• Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.

  Current medical research and opinion 20070601

• The effects of supratherapeutic doses of duloxetine on blood pressure and pulse rate.

  Journal of cardiovascular pharmacology 20070601

• Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine.

  The Journal of clinical psychiatry 20070601

• Career lifetime advances and key developments: diabetes.

  Clinical medicine (London, England) 20070601

• A validated UV spectrophotometric method for determination of duloxetine hydrochloride.

  Die Pharmazie 20070601

• Determination of duloxetine in human plasma via LC/MS and subsequent application to a pharmacokinetic study in healthy Chinese volunteers.

  Clinica chimica acta; international journal of clinical chemistry 20070501

• Tolerability and efficacy of duloxetine in a nontrial situation.

  BJOG : an international journal of obstetrics and gynaecology 20070501

• Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial.

  International clinical psychopharmacology 20070501

• Duloxetine treatment of dysthymia and double depression: an open-label trial.

  The Journal of clinical psychiatry 20070501

• Cymbalta and your blood glucose.

  Diabetes forecast 20070501

• Detrusor overactivity successfully treated with duloxetine.

  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20070501

• An independent meta-analysis using summary data for clinical response, remission, and discontinuation for any reason from the 6 pivotal phase III randomized clinical trials of duloxetine in major depressive disorder.

  Journal of clinical psychopharmacology 20070401

• Is there a place for duloxetine?

  Drug and therapeutics bulletin 20070401

• Duloxetine treatment for role functioning improvement in generalized anxiety disorder: three independent studies.

  The Journal of clinical psychiatry 20070401

• Isolation and characterisation of a phenolic impurity in a commercial sample of duloxetine.

  Journal of pharmaceutical and biomedical analysis 20070312

• [Conservative treatment of male stress incontinence].

  Der Urologe. Ausg. A 20070301

• Facial flushing associated with duloxetine use.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070301

• Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain.

  Diabetes care 20070301

• Eosinophilic pneumonia due to duloxetine.

  Chest 20070301

• Duloxetine pharmacokinetics are similar in Japanese and Caucasian subjects.

  British journal of clinical pharmacology 20070301

• QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study.

  Journal of cardiovascular pharmacology 20070301

• [Evaluation of women's preferences for the treatment of stress urinary incontinence using the paired comparisons method].

  Archivos espanoles de urologia 20070301

• Synergistic interactions between the dual serotonergic, noradrenergic reuptake inhibitor duloxetine and the non-steroidal anti-inflammatory drug ibuprofen in inflammatory pain in rodents.

  European journal of pain (London, England) 20070201

• The dual serotonin and noradrenaline reuptake inhibitor duloxetine for the treatment of interstitial cystitis: results of an observational study.

  The Journal of urology 20070201

• Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers.

  Journal of clinical psychopharmacology 20070201

• Duloxetine and hyponatremia: a report of 5 cases.

  Journal of clinical psychopharmacology 20070201

• Duloxetine-induced excessive disturbing and disabling yawning.

  Journal of clinical psychopharmacology 20070201

• Duloxetine-induced ultrarapid cycling in an adolescent with bipolar depression.

  Journal of clinical psychopharmacology 20070201

• Treatment options for patients with suboptimal response to surgery for stress urinary incontinence.

  Current medical research and opinion 20070201

• Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.

  Current medical research and opinion 20070201

• Duloxetine treatment of pediatric chronic pain and co-morbid major depressive disorder.

  Journal of child and adolescent psychopharmacology 20070201

• Planning and analysis of three-arm non-inferiority trials with binary endpoints.

  Statistics in medicine 20070130

• [Psychiatry].

  Revue medicale suisse 20070117

• Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain.

  Biological psychiatry 20070115

• Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.

  Depression and anxiety 20070101

• Use of effect size to determine optimal dose of duloxetine in major depressive disorder.

  Journal of psychiatric research 20070101

• Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.

  European urology 20070101

• Prescribing update: why choose duloxetine for depression?

  Issues in mental health nursing 20070101

• Does treatment with duloxetine for neuropathic pain impact glycemic control?

  Diabetes care 20070101

• The application of evidence-based principles of care in older persons (issue 6): urinary incontinence.

  Journal of the American Medical Directors Association 20070101

• Bleeding gums: duloxetine may be the cause.

  Journal of postgraduate medicine 20070101

• A retrospective pooled analysis of duloxetine safety in 23,983 subjects.

  Current medical research and opinion 20070101

• The efficacy of duloxetine in the treatment of premature ejaculation.

  International urology and nephrology 20070101

• Treatment of psychiatric comorbidities in a patient with becker muscular dystrophy.

  Psychosomatics 20070101

• An acute attack of porphyria in a patient taking duloxetine.

  Psychosomatics 20070101

• Pregabalin and duloxetine for the treatment of neuropathic pain disorders.

  Journal of pain & palliative care pharmacotherapy 20070101

• Suicide risk and symptom reduction in patients assigned to placebo in duloxetine and escitalopram clinical trials: analysis of the FDA summary basis of approval reports.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20070101

• An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.

  Drug safety 20070101

• [Urinary incontinence in elderly persons].

  Soins. Gerontologie 20070101

• Simple options for improving signal detection in antidepressant clinical trials.

  Psychopharmacology bulletin 20070101

• Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.

  Clinical drug investigation 20070101

• Duloxetine: a review of its use in the treatment of major depressive disorder.

  CNS drugs 20070101

• Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20070101

• Premature ejaculation: definition and drug treatment.

  Drugs 20070101

• Duloxetine for the management of diabetic peripheral neuropathic pain: response profile.

  Pain medicine (Malden, Mass.) 20070101

• Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomes.

  Pain medicine (Malden, Mass.) 20070101

• Pharmacokinetics and tolerability of duloxetine following oral administration to healthy Chinese subjects.

  Clinical pharmacokinetics 20070101

• Duloxetine in the treatment of major depressive disorder: an open-label study.

  BMC psychiatry 20070101

• The efficacy and tolerability of duloxetine in the treatment of anxious versus non-anxious depression: a post-hoc analysis of an open-label outpatient study.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20070101

• The effect of duloxetine on primary pain symptoms in Parkinson disease.

  Clinical neuropharmacology 20070101

• Antidepressant behavioral effects of duloxetine and fluoxetine in the rat forced swimming test.

  Acta cirurgica brasileira 20070101

• Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).

  Neuropsychobiology 20070101

• Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.

  Clinical therapeutics 20070101

• [Efficacy of duloxetine in the treatment of chronic daily headache].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20070101

• [Treatment of chronic back pain with antidepressant cymbalta: an experimental study].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20070101

• Duloxetine for childhood depression with pain and dissociative symptoms.

  European child & adolescent psychiatry 20061201

• Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.

  Neuropharmacology 20061201

• Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder.

  Journal of clinical psychopharmacology 20061201

• A case of hyponatremia induced by duloxetine.

  Journal of clinical psychopharmacology 20061201

• Serotonin syndrome precipitated by linezolid in a medically ill patient on duloxetine.

  Journal of clinical psychopharmacology 20061201

• Serotonin syndrome from the interaction of cyclobenzaprine with other serotoninergic drugs.

  Anesthesia and analgesia 20061201

• [Dual acting reuptake inhibitors in the treatment of depression and pain].

  Deutsche medizinische Wochenschrift (1946) 20061201

• [Duloxetine, a new therapeutic option for diabetic peripheral neuropathic pain].

  Deutsche medizinische Wochenschrift (1946) 20061201

• New developments in the treatment of urinary incontinence.

  Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20061201

• Duloxetine treatment for women awaiting continence surgery.

  International urogynecology journal and pelvic floor dysfunction 20061101

• Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?

  International clinical psychopharmacology 20061101

• Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.

  The journal of pain : official journal of the American Pain Society 20061101

• Duloxetine in the treatment of women with stress urinary incontinence: results from DESIRE (Duloxetine Efficacy and Safety for Incontinence in Racial and Ethnic populations).

  Current medical research and opinion 20061101

• Dyskinesia during treatment with duloxetine.

  Pharmacopsychiatry 20061101

• [Medication of the month. Duloxetine (Cymbalta)].

  Revue medicale de Liege 20061101

• Immediate switching from moclobemide to duloxetine may induce serotonin syndrome.

  The Journal of clinical psychiatry 20061101

• A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

  Neurology 20061024

• Duloxetine in the treatment of panic disorder.

  The international journal of neuropsychopharmacology 20061001

• Determination of drug binding to plasma proteins using competitive equilibrium binding to dextran-coated charcoal.

  Journal of pharmacokinetics and pharmacodynamics 20061001

• Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder.

  Psychopharmacology 20061001

• The use of duloxetine for stress incontinence after prostatectomy.

  BJU international 20061001

• A first look at duloxetine (Cymbalta) in a postmortem laboratory.

  Journal of analytical toxicology 20061001

• Comparative effects of clomipramine and duloxetine on detrusor and striated sphincter function in male and female rabbits.

  Archivos espanoles de urologia 20061001

• Successful treatment with duloxetine in a case of treatment refractory bulimia nervosa: a case report.

  Journal of psychopharmacology (Oxford, England) 20060901

• Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

  European psychiatry : the journal of the Association of European Psychiatrists 20060901

• Treatment benefits of duloxetine in major depressive disorder as assessed by number needed to treat.

  International clinical psychopharmacology 20060901

• Duloxetine in the treatment of major depressive disorder: an assessment of the relationship between outcomes and episode characteristics.

  International clinical psychopharmacology 20060901

• Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part II.

  Journal of psychiatric practice 20060901

• Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy in U.S. Hispanic and majority Caucasian patients.

  The Journal of clinical psychiatry 20060901

• Sample size estimation for the van Elteren test--a stratified Wilcoxon-Mann-Whitney test.

  Statistics in medicine 20060815

• N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.

  Bioorganic & medicinal chemistry letters 20060815

• Duloxetine in the treatment of major depressive disorder: comparisons of safety and tolerability in male and female patients.

  Journal of affective disorders 20060801

• Facilitatory neuromodulative effect of duloxetine on pudendal motor neurons controlling the urethral pressure: a functional urodynamic study in healthy women.

  European urology 20060701

• Case report: fulminant hepatic failure involving duloxetine hydrochloride.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060701

• [Physical complaints can overlap mental symptoms. Diffuse pain? Think about depression!].

  MMW Fortschritte der Medizin 20060608

• [Duloxetin effective in depression and pain: high remission rates obtained].

  MMW Fortschritte der Medizin 20060608

• Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range.

  Journal of psychiatric research 20060601

• Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy.

  European urology 20060601

• Duloxetine for male stress incontinence.

  European urology 20060601

• Management of depression relapse: re-initiation of duloxetine treatment or dose increase.

  Journal of psychiatric research 20060601

• Minimal clinically important differences in Incontinence Quality-of-Life scores in stress urinary incontinence.

  Urology 20060601

• Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.

  The journal of pain : official journal of the American Pain Society 20060601

• Combined use of ECT with duloxetine and olanzapine: a case report.

  The journal of ECT 20060601

• Duloxetine for neuropathic pain based on recent clinical trials.

  Current pain and headache reports 20060601

• Duloxetine in the context of current needs and issues in treatment of women with stress urinary incontinence.

  BJOG : an international journal of obstetrics and gynaecology 20060501

• What do we know about duloxetine's mode of action? Evidence from animals to humans.

  BJOG : an international journal of obstetrics and gynaecology 20060501

• Initial management of stress urinary incontinence: pelvic floor muscle training and duloxetine.

  BJOG : an international journal of obstetrics and gynaecology 20060501

• Duloxetine in women awaiting surgery.

  BJOG : an international journal of obstetrics and gynaecology 20060501

• Safety and tolerability of duloxetine in women with stress urinary incontinence.

  BJOG : an international journal of obstetrics and gynaecology 20060501

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.

  Perspectives in psychiatric care 20060501

• Prospects for the treatment of depression.

  The Australian and New Zealand journal of psychiatry 20060501

• Duloxetine 60 mg once daily in the treatment of milder major depressive disorder.

  International journal of clinical practice 20060501

• Duloxetine treatment of major depressive episodes in the course of psychotic disorders.

  Pharmacopsychiatry 20060501

• Recent developments in stress urinary incontinence in women.

  Nursing standard (Royal College of Nursing (Great Britain) : 1987) 20060501

• Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.

  The Journal of clinical psychiatry 20060501

• Interaction of duloxetine and warfarin causing severe elevation of international normalized ratio.

  JAMA 20060405

• A dose-finding study of duloxetine based on serotonin transporter occupancy.

  Psychopharmacology 20060401

• Duloxetine in the prevention of relapse of major depressive disorder: double-blind placebo-controlled study.

  The British journal of psychiatry : the journal of mental science 20060401

• Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.

  The Journal of clinical psychiatry 20060401

• Economic evaluation of duloxetine for the treatment of women with stress urinary incontinence: a Markov model comparing pharmacotherapy with pelvic floor muscle training.

  Clinical therapeutics 20060401

• Duloxetine-induced syndrome of inappropriate antidiuretic hormone secretion and seizures.

  Neurology 20060314

• Duloxetine for the treatment of stress urinary incontinence in women: an integrated analysis of safety.

  European journal of obstetrics, gynecology, and reproductive biology 20060301

• Duloxetine: a new selective and dual-acting antidepressant.

  Expert opinion on pharmacotherapy 20060301

• Acute and long-term administration of citalopram desensitizes alpha2-adrenoceptors in the rat vas deferens.

  The Journal of pharmacy and pharmacology 20060301

• Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy.

  Journal of the National Medical Association 20060301

• Exacerbation of PTSD symptoms with use of duloxetine.

  The Journal of clinical psychiatry 20060301

• Medical management of depression.

  The New England journal of medicine 20060209

• Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.

  Journal of palliative medicine 20060201

• Duloxetine in diabetic neuropathy.

  Expert opinion on pharmacotherapy 20060201

• The combination of duloxetine and bupropion for treatment-resistant major depressive disorder.

  Depression and anxiety 20060101

• The latest in treatments for incontinence in women.

  Nebraska nurse 20060101

• Is HCl duloxetine effective in the management of urinary stress incontinence after radical prostatectomy?

  Urologia internationalis 20060101

• Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons.

  BMC psychiatry 20060101

• Does duloxetine safely and effectively reduce the severity of diabetic peripheral neuropathic pain?

  Nature clinical practice. Neurology 20060101

• Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study.

  Pain medicine (Malden, Mass.) 20060101

• Power approximation for the van Elteren test based on location-scale family of distributions.

  Journal of biopharmaceutical statistics 20060101

• Tolerability of amine uptake inhibitors in urologic diseases.

  Current drug safety 20060101

• A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.

  Pain 20051215

• Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder.

  Journal of affective disorders 20051201

• An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.

  Journal of clinical psychopharmacology 20051201

• Moving beyond balance for a better antidepressant.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20051201

• Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20051201

• Stress incontinence.

  Clinical evidence 20051201

• Efficacy, tolerability, and safety of duloxetine.

  CNS spectrums 20051201

• [Duloxetine. A new preparation for patients with urinary incontinence].

  Ugeskrift for laeger 20051128

• [Treatment of urinary incontinence in the elderly woman].

  MMW Fortschritte der Medizin 20051110

• Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials.

  The Annals of pharmacotherapy 20051101

• Safety and adverse event profile of duloxetine.

  Expert opinion on drug safety 20051101

• [Brief case report. Duloxetine in Cotard syndrome].

  Psychiatrische Praxis 20051101

• A wee problem.

  Nursing standard (Royal College of Nursing (Great Britain) : 1987) 20051101

• [Pharmacotherapy of stress incontinence].

  Deutsche medizinische Wochenschrift (1946) 20051014

• Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter.

  Psychopharmacology 20051001

• Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20051001

• Duloexetine (Cymbalta) for treatment of major depressive disorder.

  American family physician 20050915

• Duloxetine associated with smoking cessation.

  The Annals of pharmacotherapy 20050901

• SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.

  CNS spectrums 20050901

• [Place of duloxetine in the treatment of stress urinary incontinence].

  Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20050901

• Detective work: reading fine print, insurers question studies of drugs; Kaiser's veteran sleuth scours medical-journal articles and sees marketing spin; doctors fear loss of choices.

  Wall Street journal (Eastern ed.) 20050824

• Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder.

  Current medical research and opinion 20050801

• Duloxetine (Cymbalta) for diabetic neuropathic pain.

  The Medical letter on drugs and therapeutics 20050801

• Duloxetine hydrochloride: a new dual-acting medication for the treatment of major depressive disorder.

  Clinical therapeutics 20050801

• Neurobiology of stress urinary incontinence: new insights and implications for treatment.

  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20050801

• Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.

  The Cochrane database of systematic reviews 20050720

• FDA warns that antidepressants may increase suicidality in adults.

  BMJ (Clinical research ed.) 20050709

• alpha(2)-Adrenoceptor involvement in the in vitro inhibitory effect of citalopram on a subpopulation of rat locus coeruleus neurons.

  European journal of pharmacology 20050704

• Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials.

  Human psychopharmacology 20050701

• Duloxetine vs. placebo in patients with painful diabetic neuropathy.

  Pain 20050701

• Pharmacotherapy for stress urinary incontinence.

  Current opinion in urology 20050701

• Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression.

  Journal of affective disorders 20050701

• Overactive bladder.

  Cleveland Clinic journal of medicine 20050701

• Biotransformations for the production of the chiral drug (S)-Duloxetine catalyzed by a novel isolate of Candida tropicalis.

  Applied microbiology and biotechnology 20050601

• Mixed incontinence.

  The Journal of urology 20050601

• Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder.

  The Journal of clinical psychiatry 20050601

• [Management of psychological symptoms and physical symptoms of depression. Rapid re-integration of patients into employment].

  MMW Fortschritte der Medizin 20050517

• [Dual mechanism of action. Remission of physical symptoms].

  MMW Fortschritte der Medizin 20050517

• Urinary incontinence: a diverse condition.

  The Journal of urology 20050501

• A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence.

  The Journal of urology 20050501

• SIGN guidelines on managing urinary incontinence.

  Nursing times 20050501

• Duloxetine: pharmacoeconomic implications of an antidepressant that alleviates painful physical symptoms.

  Expert opinion on pharmacotherapy 20050501

• Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine.

  Journal of clinical psychopharmacology 20050401

• Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies.

  Journal of psychiatric research 20050301

• Duloxetine for the treatment of major depressive disorder in older patients.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20050301

• Duloxetine fights major depressive disorder.

  The Nurse practitioner 20050301

• Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression.

  Current medical research and opinion 20050301

• Duloxetine: a dual serotonin-norepinephrine reuptake inhibitor for treatment of major depressive disorder.

  Pharmacotherapy 20050301

• Duloxetine for management of stress urinary incontinence.

  The American journal of geriatric pharmacotherapy 20050301

• Neonatal brain injury.

  The New England journal of medicine 20050224

• [Stress incontinence. How does the bladder become leakproof again?].

  MMW Fortschritte der Medizin 20050210

• Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects.

  Psychopharmacology 20050201

• Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents.

  The Journal of pharmacology and experimental therapeutics 20050201

• Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain.

  Neuropharmacology 20050201

• 2004 drug approval highlights: FDA update.

  The Nurse practitioner 20050201

• Duloxetine pharmacokinetics in cirrhotics compared with healthy subjects.

  International journal of clinical pharmacology and therapeutics 20050201

• Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.

  Journal of psychiatric research 20050101

• Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.

  BMC psychiatry 20050101

• Impact of duloxetine on quality of life for women with symptoms of urinary incontinence.

  International urogynecology journal and pelvic floor dysfunction 20050101

• The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression.

  Current pharmaceutical design 20050101

• [Change in the point of view].

  Krankenpflege Journal 20050101

• Cost-effectiveness inferences from bootstrap quadrant confidence levels: three degrees of dominance.

  Journal of biopharmaceutical statistics 20050101

• Duloxetine for the treatment of major depressive disorder in women ages 40 to 55 years.

  Psychosomatics 20050101

• Time course of depression-symptom improvement during treatment with duloxetine.

  Depression and anxiety 20050101

• The role of venlafaxine and duloxetine in the treatment of depression with decremental changes in somatic symptoms of pain, chronic pain, and the pharmacokinetics and clinical considerations of duloxetine pharmacotherapy.

  American journal of therapeutics 20050101

• [A challenge].

  Krankenpflege Journal 20050101

• A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.

  Pain medicine (Malden, Mass.) 20050101

• [Depression and pain: novel clinical, neurobiological and psychopharmacological data].

  Psychiatria polska 20050101

• Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20050101

• [Duloxetine (Yentreve) in the general practice test: recommendation by the experts. Effective and tolerable therapy of symptoms in female stress incontinence].

  Krankenpflege Journal 20050101

• Duloxetine: a dual reuptake inhibitor.

  The Annals of pharmacotherapy 20041201

• Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20041201

• Some antipsychotics' effect on suicide; duloxetine's promise for elderly.

  Behavioral healthcare tomorrow 20041201

• [Review of antidepressants from the TCAs to the third generation drugs].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20041201

• Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.

  The Journal of pharmacology and experimental therapeutics 20041101

• [Urinary stress incontinence in women].

  Aktuelle Urologie 20041101

• The brain leads the way.

  BJU international 20041101

• Does the new antidepressant duloxetine (Cymbalta) have any advantages over other antidepressant drugs?

  The Harvard mental health letter 20041101

• Duloxetine hydrochloride.

  Nature reviews. Drug discovery 20041101

• Duloxetine.

  Journal of psychiatric practice 20041101

• Home treatment for women with stress urinary incontinence.

  Nursing times 20041101

• [New options in pharmacological treatment of urinary stress incontinence in women].

  Ceska gynekologie 20041101

• Molecule of the month. Duloxetine hydrochloride.

  Drug news & perspectives 20041101

• Duloxetine (Cymbalta): a new SNRI for depression.

  The Medical letter on drugs and therapeutics 20041011

• [Pharmaceutical treatment of stress incontinence. New approaches via a direct effect of duloxetine on Onuf's nucleus].

  Der Urologe. Ausg. A 20041001

• Clinical experience with dual action antidepressants in different chronic pain syndromes.

  Human psychopharmacology 20041001

• Preview of new drugs for overactive bladder and incontinence: darifenacin, solifenacin, trospium, and duloxetine.

  Current urology reports 20041001

• Pharmacological treatment of women awaiting surgery for stress urinary incontinence.

  Obstetrics and gynecology 20040901

• Balanced treatments for fibromyalgia.

  Arthritis and rheumatism 20040901

• A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.

  Arthritis and rheumatism 20040901

• New drugs and dosage forms.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20040901

• Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.

  Clinical therapeutics 20040901

• Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression.

  Drugs of today (Barcelona, Spain : 1998) 20040901

• Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine.

  Journal of clinical psychopharmacology 20040801

• Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.

  Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20040801

• [Duloxetine in the treatment of urinary incontinence in women].

  Minerva ginecologica 20040801

• [The 10-minute consultation. Urinary incontinence in a woman].

  MMW Fortschritte der Medizin 20040722

• Synthesis and biological activity of some known and putative duloxetine metabolites.

  Bioorganic & medicinal chemistry letters 20040705

• Mechanisms for the inhibition of genital vascular responses by antidepressants in a female rabbit model.

  The Journal of pharmacology and experimental therapeutics 20040701

• New developments in the management of stress urinary incontinence.

  BJU international 20040701

• Role of serotonin and noradrenaline in stress urinary incontinence.

  BJU international 20040701

• Duloxetine: an innovative approach for treating stress urinary incontinence.

  BJU international 20040701

• Central nervous system control of the lower urinary tract: new pharmacological approaches to stress urinary incontinence in women.

  The Journal of urology 20040701

• Duloxetine's role in the treatment of depression and associated painful physical symptoms.

  The Journal of clinical psychiatry 20040701

• The effect of previous treatment experience and incontinence severity on the placebo response of stress urinary incontinence.

  American journal of obstetrics and gynecology 20040701

• New approaches in the pharmacological treatment of stress urinary incontinence.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20040701

• Duloxetine: a new approach for treating stress urinary incontinence.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20040701

• Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles.

  Circulation 20040629

• Validation of a clinical algorithm to diagnose stress urinary incontinence for large studies.

  The Journal of urology 20040601

• [Update on medical treatment of female stress urinary incontinence].

  Gynecologie, obstetrique & fertilite 20040601

• Effect of duloxetine on tolterodine pharmacokinetics in healthy volunteers.

  British journal of clinical pharmacology 20040501

• Stress incontinence: help at hand.

  BJU international 20040501

• Stress urinary incontinence in women.

  Journal of the American Academy of Nurse Practitioners 20040501

• The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?

  The Journal of clinical psychiatry 20040401

• Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence.

  BJOG : an international journal of obstetrics and gynaecology 20040301

• [Duloxetine and other tricyclic antidepressive agents: pharmacodynamic effects in the lower urinary tract].

  Actas urologicas espanolas 20040301

• [Successful phase III study with serotonin-noradrenaline reuptake inhibitor. Soon a drug to control stress incontinence].

  MMW Fortschritte der Medizin 20040212

• Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.

  Biological psychiatry 20040201

• Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.

  BJU international 20040201

• Metabolism of the newest antidepressants: comparisons with related predecessors.

  IDrugs : the investigational drugs journal 20040201

• Effect of age on the pharmacokinetics of duloxetine in women.

  British journal of clinical pharmacology 20040101

• Effects of duloxetine on painful physical symptoms associated with depression.

  Psychosomatics 20040101

• Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine.

  The Journal of clinical psychiatry 20040101

• [Physical recovery is part of remission].

  Krankenpflege Journal 20040101

• Common pathways of depression and pain.

  The Journal of clinical psychiatry 20040101

• Reboxetine: a norepinephrine selective reuptake pump inhibitor.

  Journal of psychiatric practice 20040101

• The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials.

  BMC psychiatry 20040101

• [Clinical management of patients with depression and cardiac disease].

  Vertex (Buenos Aires, Argentina) 20040101

• Duloxetine: in stress urinary incontinence.

  Drugs 20040101

• [FDA approval for the antidepressive drug Cymbalta].

  Krankenpflege Journal 20040101

• SNRIs in the management of acute major depressive disorder.

  The Journal of clinical psychiatry 20040101

• [Stress incontinence in general practice].

  Krankenpflege Journal 20040101

• [Duloxetine reduces pain and depression].

  Krankenpflege Journal 20040101

• [Duloxetine receives positive recommendation by the Scientific Committee of EMEA for treatment of depression].

  Krankenpflege Journal 20040101

• New tools 2004.

  Diabetes self-management 20040101

• [Duloxetin--a new tool in pharmacotherapy of urinary incontinence in women].

  Urologiia (Moscow, Russia : 1999) 20040101

• [Urinary incontinence: new pharmacologic therapies].

  Revista de medicina de la Universidad de Navarra 20040101

• Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.

  Bioorganic & medicinal chemistry letters 20031215

• Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.

  Neuropharmacology 20031201

• Innovations in pharmacotherapy for stress urinary incontinence.

  International urogynecology journal and pelvic floor dysfunction 20031201

• Physical symptoms comorbid with depression and the new antidepressant duloxetine.

  Journal of psychosocial nursing and mental health services 20031201

• Update on overactive bladder: pharmacologic approaches on the horizon.

  Current urology reports 20031001

• Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence.

  The Journal of urology 20031001

• Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence.

  Urology 20031001

• Serotonergic modulation of bladder afferent pathways.

  Urology 20031001

• Pharmacologic treatment of stress urinary incontinence: expectations for outcome.

  Urology 20031001

• Duloxetine in the long-term treatment of major depressive disorder.

  The Journal of clinical psychiatry 20031001

• A word of caution about the implied role for duloxetine in pain management.

  The Journal of clinical psychiatry 20031001

• Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030901

• Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects.

  Drug metabolism and disposition: the biological fate of chemicals 20030901

• Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence.

  Expert opinion on investigational drugs 20030901

• Role of 5-HT receptors in treatment of overactive bladder.

  Drugs of today (Barcelona, Spain : 1998) 20030801

• Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response.

  Obstetrics and gynecology 20030701

• Validation of two global impression questionnaires for incontinence.

  American journal of obstetrics and gynecology 20030701

• Neural control of the urethra and development of pharmacotherapy for stress urinary incontinence.

  BJU international 20030501

• Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers.

  Clinical pharmacology and therapeutics 20030301

• [Depression also effects the body].

  Pharmazie in unserer Zeit 20030101

• Analgesic effects of antidepressants.

  The Journal of clinical psychiatry 20030101

• New hope in the treatment of painful symptoms in depression.

  Current opinion in investigational drugs (London, England : 2000) 20030101

• Physical symptoms of depression: unmet needs in special populations.

  The Journal of clinical psychiatry 20030101

• The development of new antidepressants: focus on duloxetine and escitalopram.

  Harvard review of psychiatry 20030101

• Duloxetine in treatment of anxiety symptoms associated with depression.

  Depression and anxiety 20030101

• Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.

  The Journal of clinical psychiatry 20030101

• Pharmacological agents used for the treatment of stress urinary incontinence in women.

  Current medical research and opinion 20030101

• [Duloxetine and other tricyclic antidepressants: pharmacodynamic effects in the lower urinary tract].

  Actas urologicas espanolas 20030101

• [18 million sick days due to depressive illnesses. New prospects in therapy of depression].

  Krankenpflege Journal 20030101

• Comparison of the thermogenic and hypophagic effects of sibutramine's metabolite 2 and other monoamine reuptake inhibitors.

  European journal of pharmacology 20020927

• Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats.

  Life sciences 20020802

• Duloxetine Eli Lilly.

  Current opinion in investigational drugs (London, England : 2000) 20020801

• Duloxetine versus placebo in the treatment of stress urinary incontinence.

  American journal of obstetrics and gynecology 20020701

• Somatic symptoms, depression, and antidepressant treatment.

  The Journal of clinical psychiatry 20020401

• Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.

  The Journal of clinical psychiatry 20020401

• Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.

  The Journal of clinical psychiatry 20020301

• Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?

  Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques 20020101

• Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression.

  Journal of psychiatric research 20020101

• Duloxetine pharmacology: profile of a dual monoamine modulator.

  CNS drug reviews 20020101

• Duloxetine for the treatment of major depressive disorder.

  Psychopharmacology bulletin 20020101

• Can monoamine-based therapies be improved?

  The Journal of clinical psychiatry 20020101

• Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011201

• Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010501